Loading
NYSEHealthcareMedical - Instruments & Supplies
Latest quote
$121.81
+$1.38 · +1.15%
AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.
Regular session
$120.53
−$1.28 · -1.05%
Regular session · ET · Market data may be delayed.
AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.
Day range
Current $120.53
52-week range
Current $120.53
Regular session · ET · Market data may be delayed.
GoAI Score
Buy
Valuation
85
Deep Value
Sentiment
60
Mixed
Risk
25
Moderate Risk
Momentum
42
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.
Day range
Current $120.53
52-week range
Current $120.53
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.78B USD | 3.58B USD | 3.49B USD | 3.32B USD | 3.23B USD |
| Cost of goods sold | 2.66B USD | 2.23B USD | 2.22B USD | 2.16B USD | 2.07B USD |
| Gross profit | 1.12B USD | 1.36B USD | 1.26B USD | 1.16B USD | 1.16B USD |
| Research and development | 105.1M USD | — | — | — | 99.8M USD |
| Selling, general, and administrative | 499.94M USD | 582.23M USD | 565.78M USD | 544.26M USD | 551.24M USD |
| Operating expenses | 605.04M USD | 859.01M USD | 859.38M USD | 784.57M USD | 809.34M USD |
| Interest income | 11.68M USD | 12.1M USD | 4.37M USD | 2.7M USD | 3.67M USD |
| Interest expense | 52.74M USD | 43.9M USD | 40.42M USD | 40.83M USD | 30.28M USD |
| Depreciation and amortization | 287.36M USD | 263.78M USD | 248.59M USD | 233.71M USD | 234.85M USD |
| Operating income | 512.34M USD | 496.5M USD | 404.02M USD | 379.27M USD | 347.35M USD |
| Net income | 392.79M USD | 374.54M USD | 284.49M USD | 239.29M USD | 244.1M USD |
Company facts updated Oct 9, 2026.
Cash distributions grouped by calendar year; partial years are marked.
$1.83
2025 complete year+22.0% since 2021
2026 partial: $1.44
$1.50
2,021
$1.52
2,022
$1.58
2,023
$1.72
2,024
$1.83
2,025
$1.44
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Jul 30, 2026 | $0.48Quarterly | Jul 30, 2026 | Aug 20, 2026 |
Dividend | May 6, 2026 | $0.48Quarterly | May 6, 2026 | May 27, 2026 |
Dividend | Feb 4, 2026 | $0.48Quarterly | Feb 4, 2026 | Feb 25, 2026 |
Dividend | Oct 23, 2025 | $0.48Quarterly | Oct 23, 2025 | Nov 13, 2025 |
Dividend | Jul 24, 2025 | $0.45Quarterly | Jul 24, 2025 | Aug 14, 2025 |
Dividend | May 1, 2025 | $0.45Quarterly | May 1, 2025 | May 22, 2025 |
Ex-dividend Jul 30, 2026
$0.48
Quarterly
Record Jul 30, 2026 · Payment Aug 20, 2026
Ex-dividend May 6, 2026
$0.48
Quarterly
Record May 6, 2026 · Payment May 27, 2026
Ex-dividend Feb 4, 2026
$0.48
Quarterly
Record Feb 4, 2026 · Payment Feb 25, 2026
Ex-dividend Oct 23, 2025
$0.48
Quarterly
Record Oct 23, 2025 · Payment Nov 13, 2025
Ex-dividend Jul 24, 2025
$0.45
Quarterly
Record Jul 24, 2025 · Payment Aug 14, 2025
Ex-dividend May 1, 2025
$0.45
Quarterly
Record May 1, 2025 · Payment May 22, 2025
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI267.2M0.01%2.3T USD0.03%$380.92+0.36%
Vanguard Morningstar Small-Cap ETFVB193.28M0.10%185.3B USD0.03%$288.49+0.30%
Vanguard Morningstar Small-Cap Value ETFVBR122.74M0.18%68.2B USD0.05%$234.03+0.05%
Vanguard Extended Market ETFVXF97.61M0.10%95.4B USD0.05%$234.19+0.45%
Dimensional - US Targeted Value ETFDFAT72.51M0.24%30B USD0.33%$67.46-0.15%
State Street SPDR S&P Dividend ETFSDY68.41M0.33%20.45B USD0.35%$149.24-0.09%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY57.99M0.22%25.53B USD0.23%$667.21+0.14%
Vanguard Dividend Appreciation ETFVIG47.55M0.04%132.4B USD0.04%$238.22+0.35%Vanguard Morningstar Total Stock Market ETFVTIVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Value ETFVBRVanguard Extended Market ETFVXFDimensional - US Targeted Value ETFDFATState Street SPDR S&P Dividend ETFSDYState Street SPDR S&P MIDCAP 400 ETF TrustMDYVanguard Dividend Appreciation ETFVIGAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
